Inspire Medical Systems, Inc. is focused on delivering a breakthrough treatment for people with obstructive sleep apnea (OSA). The Company developed the world’s first fully implanted neurostimulation device approved by the FDA for the treatment of OSA. The Inspire system uses well-established neurostimulation technologies and incorporates a proprietary algorithm that stimulates key airway muscles based on a patient’s unique breathing patterns. Its therapy is designed to reduce OSA severity and improve a quality of life for patients living with this challenging condition.
Market capitalization (14-Jun-2018)
Closing share price (14-Jun-2018)